246 related articles for article (PubMed ID: 27027900)
1. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies.
Gámez-Valero A; Prada-Dacasa P; Santos C; Adame-Castillo C; Campdelacreu J; Reñé R; Gascón-Bayarri J; Ispierto L; Álvarez R; Ariza A; Beyer K
Mov Disord; 2016 Jul; 31(7):1066-70. PubMed ID: 27027900
[TBL] [Abstract][Full Text] [Related]
2. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters.
Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S
Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223
[TBL] [Abstract][Full Text] [Related]
3. High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.
Shiner T; Mirelman A; Gana Weisz M; Bar-Shira A; Ash E; Cialic R; Nevler N; Gurevich T; Bregman N; Orr-Urtreger A; Giladi N
JAMA Neurol; 2016 Dec; 73(12):1448-1453. PubMed ID: 27723861
[TBL] [Abstract][Full Text] [Related]
4. The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews.
Shiner T; Mirelman A; Rosenblum Y; Kavé G; Weisz MG; Bar-Shira A; Goldstein O; Thaler A; Gurevich T; Orr-Urtreger A; Giladi N; Bregman N
J Alzheimers Dis; 2021; 80(3):1221-1229. PubMed ID: 33646158
[TBL] [Abstract][Full Text] [Related]
5. Glucocerebrosidase mutations and neuropsychiatric phenotypes in Parkinson's disease and Lewy body dementias: Review and meta-analyses.
Creese B; Bell E; Johar I; Francis P; Ballard C; Aarsland D
Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):232-241. PubMed ID: 28548708
[TBL] [Abstract][Full Text] [Related]
6. Glucocerebrosidase gene variants are accumulated in idiopathic REM sleep behavior disorder.
Gámez-Valero A; Iranzo A; Serradell M; Vilas D; Santamaria J; Gaig C; Álvarez R; Ariza A; Tolosa E; Beyer K
Parkinsonism Relat Disord; 2018 May; 50():94-98. PubMed ID: 29487000
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies.
Moors TE; Paciotti S; Ingrassia A; Quadri M; Breedveld G; Tasegian A; Chiasserini D; Eusebi P; Duran-Pacheco G; Kremer T; Calabresi P; Bonifati V; Parnetti L; Beccari T; van de Berg WDJ
Mol Neurobiol; 2019 Feb; 56(2):1344-1355. PubMed ID: 29948939
[TBL] [Abstract][Full Text] [Related]
8. Effect of GBA gene variants on clinical characteristics of dementia with Lewy bodies: a review and meta-analyses.
Liu L; Li J; Quan W; Qin Y; Zhang Q; Pei X; Su H; Xu J; Chen J
Neurol Sci; 2022 Jun; 43(6):3541-3550. PubMed ID: 35332438
[TBL] [Abstract][Full Text] [Related]
9. Clinicogenetic study of GBA mutations in patients with familial Parkinson's disease.
Li Y; Sekine T; Funayama M; Li L; Yoshino H; Nishioka K; Tomiyama H; Hattori N
Neurobiol Aging; 2014 Apr; 35(4):935.e3-8. PubMed ID: 24126159
[TBL] [Abstract][Full Text] [Related]
10. Glucocerebrosidase mRNA is Diminished in Brain of Lewy Body Diseases and Changes with Disease Progression in Blood.
Perez-Roca L; Adame-Castillo C; Campdelacreu J; Ispierto L; Vilas D; Rene R; Alvarez R; Gascon-Bayarri J; Serrano-Munoz MA; Ariza A; Beyer K
Aging Dis; 2018 Apr; 9(2):208-219. PubMed ID: 29896411
[TBL] [Abstract][Full Text] [Related]
11. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.
Nalls MA; Duran R; Lopez G; Kurzawa-Akanbi M; McKeith IG; Chinnery PF; Morris CM; Theuns J; Crosiers D; Cras P; Engelborghs S; De Deyn PP; Van Broeckhoven C; Mann DM; Snowden J; Pickering-Brown S; Halliwell N; Davidson Y; Gibbons L; Harris J; Sheerin UM; Bras J; Hardy J; Clark L; Marder K; Honig LS; Berg D; Maetzler W; Brockmann K; Gasser T; Novellino F; Quattrone A; Annesi G; De Marco EV; Rogaeva E; Masellis M; Black SE; Bilbao JM; Foroud T; Ghetti B; Nichols WC; Pankratz N; Halliday G; Lesage S; Klebe S; Durr A; Duyckaerts C; Brice A; Giasson BI; Trojanowski JQ; Hurtig HI; Tayebi N; Landazabal C; Knight MA; Keller M; Singleton AB; Wolfsberg TG; Sidransky E
JAMA Neurol; 2013 Jun; 70(6):727-35. PubMed ID: 23588557
[TBL] [Abstract][Full Text] [Related]
12. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia.
Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB
Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958
[TBL] [Abstract][Full Text] [Related]
13. Association of glucocerebrosidase mutations with dementia with lewy bodies.
Clark LN; Kartsaklis LA; Wolf Gilbert R; Dorado B; Ross BM; Kisselev S; Verbitsky M; Mejia-Santana H; Cote LJ; Andrews H; Vonsattel JP; Fahn S; Mayeux R; Honig LS; Marder K
Arch Neurol; 2009 May; 66(5):578-83. PubMed ID: 19433657
[TBL] [Abstract][Full Text] [Related]
14. Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.
Crosiers D; Verstraeten A; Wauters E; Engelborghs S; Peeters K; Mattheijssens M; De Deyn PP; Theuns J; Van Broeckhoven C; Cras P
Neurosci Lett; 2016 Aug; 629():160-164. PubMed ID: 27397011
[TBL] [Abstract][Full Text] [Related]
15. Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders.
Mata IF; Samii A; Schneer SH; Roberts JW; Griffith A; Leis BC; Schellenberg GD; Sidransky E; Bird TD; Leverenz JB; Tsuang D; Zabetian CP
Arch Neurol; 2008 Mar; 65(3):379-82. PubMed ID: 18332251
[TBL] [Abstract][Full Text] [Related]
16.
Riboldi GM; Di Fonzo AB
Cells; 2019 Apr; 8(4):. PubMed ID: 31010158
[TBL] [Abstract][Full Text] [Related]
17. Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies.
van der Lee SJ; van Steenoven I; van de Beek M; Tesi N; Jansen IE; van Schoor NM; Reinders MJT; Huisman M; Scheltens P; Teunissen CE; Holstege H; van der Flier WM; Lemstra AW
J Alzheimers Dis; 2021; 83(1):269-279. PubMed ID: 34308904
[TBL] [Abstract][Full Text] [Related]
18. Distinguishing Dementia With Lewy Bodies From Alzheimer Disease: What is the Influence of the GBA Genotype in Ashkenazi Jews?
Bregman N; Kavé G; Mirelman A; Thaler A; Gana Weisz M; Bar-Shira A; Orr-Urtreger A; Giladi N; Shiner T
Alzheimer Dis Assoc Disord; 2019; 33(3):279-281. PubMed ID: 30640255
[TBL] [Abstract][Full Text] [Related]
19. Features of
Malek N; Weil RS; Bresner C; Lawton MA; Grosset KA; Tan M; Bajaj N; Barker RA; Burn DJ; Foltynie T; Hardy J; Wood NW; Ben-Shlomo Y; Williams NW; Grosset DG; Morris HR;
J Neurol Neurosurg Psychiatry; 2018 Jul; 89(7):702-709. PubMed ID: 29378790
[TBL] [Abstract][Full Text] [Related]
20. Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels.
Gündner AL; Duran-Pacheco G; Zimmermann S; Ruf I; Moors T; Baumann K; Jagasia R; van de Berg WDJ; Kremer T
Neurobiol Dis; 2019 Jan; 121():205-213. PubMed ID: 30236861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
